A Single and Multiple Ascending Dose Study of LAD603 in Healthy Subjects

LAD603 Study is for healthy adults aged 18-65 to check if LAD603 is safe and how it works in the body. In Part 1, participants take one dose of LAD603, and in Part 2, they take multiple doses. The study lasts 8 weeks for Part 1 and 14 weeks for Part 2. Healthy subjects with no major health issues like heart or liver problems can join. Women must not be pregnant or breastfeeding. 🚫 People who smoke, have infections, or recent surgeries can't join. Participants must avoid certain medications and alcohol. The study checks how participants tolerate the drug and how the body uses it (pharmacokinetics, PK). PK is how the drug is absorbed, distributed, and eliminated. Immunogenicity checks if the body reacts to the drug. Participants will be checked for any side effects or changes in health. It's important to be honest about medical history and follow the rules for the safety of everyone involved.

• Study Length: 8 to 14 weeks
• Eligibility: Healthy adults, 18-65 years
• Restrictions: No recent surgeries, infections, or smoking